Registering a CAGR of 14.25% over the forecast period, the market value of Vaccine is expected to reach US$ 154.60 billion in the year 2027.
Vaccines are the most effective and cost-effective way to protect billions of people worldwide. Vaccine development has the potential to transform health by removing the burden of life-threatening infectious diseases from the populations of affluent countries. According to the World Health Organization (WHO), immunisation awareness and government initiatives have helped prevent 2-3 million deaths each year. Increased investments, as well as company mergers and partnerships, are boosting global product production and sales.
To meet the adherence and needs of immunisation policies to eradicate endemic diseases, global product supply increased, which is a significant driver of market growth. Government foundations, hospitals, and pharmaceutical companies are emphasising regular immunisation and providing cost-effective immunisation to people all over the world. Government surveillance has increased in all countries to ensure that everyone is vaccinated at a low or no cost. Another major factor driving market growth is the competitive pipeline, which includes products from both emerging and major players. Because the market is heterogeneous and vast, these players are battling for regulatory approvals for their products. Many companies' main challenge is continuous R&D and a focus on launching novel products.
The report aspects discussed the profile of the top manufacturers of the global Vaccine market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Vaccine Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
January 25, 2022: Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age--
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age.
September 29, 2021: Mitsubishi Tanabe to bring plant-derived COVID vaccine to Japan--
Mitsubishi Tanabe Pharma has decided to launch the world's first plant-based vaccine in Japan, Nikkei has learned, potentially paving the way to stable COVID-19 vaccine supplies for a country that so far has approved only overseas-made doses.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America generated USD 29.43 billion in revenue in 2020 and is expected to dominate the global market during the forecast period. The market in North America is expected to grow steadily and to hold the dominant market share due to a variety of factors such as vaccination awareness, the presence of strong manufacturers, and secure government policy regarding health welfare. It also focuses on implementing immunisation across North American countries by enacting appropriate financing policies. The market value of Asia Pacific is expected to skyrocket in the coming years. Asia Pacific countries have varying levels of economic development, which results in a variety of approaches to immunisation. Because of China's and India's growing populations, Japan dominates the Asia Pacific market with the highest market share. This is the primary reason for the increased demand for injections.
The Vaccine Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Vaccine Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 14.25% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 156 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Vaccine Market?
The Vaccine Market is growing at a CAGR of 14.25% over the next 5 years.
Who are the key players in Vaccine Market?
AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties
What are the significant types of Vaccine Market?
Varicella Vaccine, Influenza Vaccine, Polio Vaccine, Hepatitis A Vaccine, Rabies Vaccine, BCG Vaccine, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Others
What are the major end-use applications of Vaccine Market?
For Adult, For Child
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.